Form 4: Director Karen Prange Acquires AtriCure Shares

Director Karen Prange acquired 6,144 shares of AtriCure, Inc. common stock through a Restricted Stock Award.

Summary

• Karen Prange, a Director at AtriCure, Inc., acquired 6,144 shares of common stock on May 18, 2026.
• These shares were granted under the AtriCure, Inc. 2023 Stock Incentive Plan as a Restricted Stock Award.
• The acquired shares are subject to vesting upon the one-year anniversary of the grant date.
• Following this transaction, Prange beneficially owns 29,373 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock award to a director rather than an open market purchase or sale.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition is part of a formal stock incentive plan, indicating a structured approach to employee and director compensation.

Risks

• The shares acquired are subject to vesting, meaning they are not fully owned by the director until the one-year anniversary of the grant date.
• Potential for insider selling if the director decides to sell shares upon vesting.

Future Outlook

The shares acquired are subject to vesting on the one-year anniversary of the grant date, indicating a future point at which the director will have full beneficial ownership.

Industry Context

StockSavvy.ai notes that insider stock awards are a common practice in the medical device industry to align management and director interests with those of shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but the vesting schedule means immediate impact on share ownership is limited.

Next Steps

• The shares will vest upon the one-year anniversary of the grant date.

Key Dates

Keywords

AtriCure, ATRC, Form 4, Insider Transaction, Restricted Stock Award, Stock Incentive Plan, Director, Beneficial Ownership